Exosomes derived from mesenchymal stem cells curbs the progression of clear cell renal cell carcinoma through T-cell immune response

2021 ◽  
Author(s):  
Daoyuan Li ◽  
Feifei Lin ◽  
Guoping Li ◽  
Fanchang Zeng
2019 ◽  
Vol 65 (2) ◽  
pp. 95-102
Author(s):  
Łukasz Szymanski ◽  
Igor Helbrecht ◽  
Michał Fiedorowicz ◽  
Damian Matak ◽  
Ewa Bartnik ◽  
...  

Raki stanowią 85% guzów nerki. W Polsce każdego roku raka nerki rozpoznaje się u prawie czterech tysięcy osób, a ponad dwa tysiące z nich umiera. Znanych jest kilka rodzajów raka nerki, spośród których najczęściej występującym jest rak jasnokomórkowy (ang. clear cell Renal Cell Carcinoma; ccRCC), który występuje w 80-90 proc. wszystkich przypadków raka nerki. ccRCC należy do nowotworów opornych na leczenie chemiczne i radioterapię. Coraz więcej danych wskazuje iż masa nowotworu powstaje w efekcie podziałów i różnicowania niewielkiej liczby komórek zwanych komórkami macierzystymi nowotworu (komórkami inicjującymi guz ang. cancer stem cells - CSC). CSC są nie tylko odpowiedzialne za rozwój nowotworu, ale także za wznowę, progresję choroby i jej oporność na chemio- i radioterapię. W pracy omówiono pochodzenie CSC w raku nerki, ze szczególnym uwzględnieniem podtypu jasnokomórkowego.


2019 ◽  
Vol 18 (1) ◽  
Author(s):  
Lu Wang ◽  
Guang Yang ◽  
Danfeng Zhao ◽  
Jiaqi Wang ◽  
Yang Bai ◽  
...  

Abstract Background Clear cell renal cell carcinoma (CCRCC) is characterized by a highly metastatic potential. The stromal communication between stem cells and cancer cells critically influences metastatic dissemination of cancer cells. Methods The effect of exosomes isolated from cancer stem cells (CSCs) of CCRCC patients on the progress of epithelial-mesenchymal transition (EMT) and lung metastasis of CCRCC cells were examined. Results CSCs exosomes promoted proliferation of CCRCC cells and accelerated the progress of EMT. Bioactive miR-19b-3p transmitted to cancer cells by CSC exosomes induced EMT via repressing the expression of PTEN. CSCs exosomes derived from CCRCC patients with lung metastasis produced the strongest promoting effect on EMT. Notably, CD103+ CSC exosomes were enriched in tumor cells and in lung as well, highlighting the organotropism conferred by CD103. In addition, CD103+ exosomes were increased in blood samples from CCRCC patients with lung metastasis. Conclusions CSC exosomes transported miR-19b-3p into CCRCC cells and initiated EMT promoting metastasis. CD103+ acted to guide CSC exosomes to target cancer cells and organs, conferring the higher metastatic capacity of CCRCC to lungs, suggesting CD103+ exosomes as a potential metastatic diagnostic biomarker. Graphical abstract ᅟ


2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Craig Gedye ◽  
Danylo Sirskyj ◽  
Nazleen C. Lobo ◽  
Jalna Meens ◽  
Elzbieta Hyatt ◽  
...  

2017 ◽  
Vol 23 (15) ◽  
pp. 4416-4428 ◽  
Author(s):  
Nicolas A. Giraldo ◽  
Etienne Becht ◽  
Yann Vano ◽  
Florent Petitprez ◽  
Laetitia Lacroix ◽  
...  

2021 ◽  
Vol 9 (2) ◽  
pp. e001823
Author(s):  
Siyuan Dai ◽  
Han Zeng ◽  
Zhaopei Liu ◽  
Kaifeng Jin ◽  
Wenbin Jiang ◽  
...  

BackgroundChemokine (C-X-C motif) ligand 13 (CXCL13) was known as a selective chemotaxis for B cells, a product of follicular helper CD4+T cells (TFH) and a contributor to tertiary lymphoid structures (TLS). Although secretion and function of CXCL13 produced by TFH have been deeply explored, the immune function and prognostic significance of CXCL13 secreted by CD8+T cells still remain unrevealed. This study aims to investigate the clinical merit of CXCL13+CD8+T cells in clear cell renal cell carcinoma (ccRCC).MethodsWe analyzed prognostic value and immune contexture that associated with CXCL13+CD8+T cells infiltration level in a total of 755 patients from Zhongshan Hospital cohort (n=223) and The Cancer Genome Atlas cohort (n=532). In vitro analyses were conducted on 42 samples of resected tumor tissue from Zhongshan Hospital in order to detect the immune status of CXCL13+CD8+T cells and total CD8+T cells. Immunohistochemistry (IHC) and flow cytometry were applied to characterize immune cells and portray the tumor microenvironment (TME) in ccRCC.ResultsIntratumoral CXCL13+CD8+T cells abundance was associated with inferior overall survival and disease-free survival. CXCL13+CD8+T cells possessed higher level of immune checkpoints like programmed cell-death protein 1 (PD-1), T-cell immunoglobulin mucin 3 (Tim-3), T cell immunoreceptor with Ig and ITIM domains (TIGIT) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), higher Ki-67 expression and lower tumor necrosis factor α (TNF-α), interferon γ (IFN-γ) expression. Total CD8+T cells in high-level CXCL13+CD8+T cells infiltration subgroup exhibited elevated exhausted markers (PD-1, Tim-3, TIGIT) and descended activated markers (TNF-α, IFN-γ) without quantity variance. Furthermore, the abundance of intratumoral CXCL13+CD8+T cell was correlated with immunoevasive TME accompanied by increased T helper 2 cells, tumor-associated macrophages, Foxp3+ regulatory T cells, TLS and decreased natural killer cells, GZMB+ cells.ConclusionsIntratumoral CXCL13+CD8+T cells infiltration indicated inferior clinical outcome in patients with ccRCC. CXCL13+CD8+T cells possessed increased exhausted markers, decreased effector molecules and better proliferation ability. CXCL13+CD8+T cells abundance impaired total CD8+T cells’ immune function. Intratumoral CXCL13+CD8+T cells abundance was associated with immunoevasive contexture. The abundance of CXCL13+CD8+T cells was an independent prognosticator and a potential immunotherapeutic target marker for ccRCC treatment.


2013 ◽  
Vol 2 (3) ◽  
pp. e23562 ◽  
Author(s):  
Stefanie Regine Dannenmann ◽  
Julia Thielicke ◽  
Martina Stöckli ◽  
Claudia Matter ◽  
Lotta von Boehmer ◽  
...  

2013 ◽  
Vol 19 (3) ◽  
pp. 545-551 ◽  
Author(s):  
Tamara Nikuševa-Martić ◽  
Ljiljana Šerman ◽  
Martina Zeljko ◽  
Željko Vidas ◽  
Slavko Gašparov ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document